A Study of JNJ-64304500 Following Subcutaneous Injection in Healthy Chinese Adult Participants

NCT04712006 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision.

Conditions

Healthy

Interventions

DRUG: JNJ-64304500

Sponsor

Janssen Research & Development, LLC